Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 8 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

7Total
Not Applicable (5)
P 1 (1)
P 4 (1)

Trial Status

Completed6
Active Not Recruiting1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (8)

Research Network

Activity Timeline